Table 1.
Baseline Characteristics of Community Pharmacists by Practice Type and Practice Location
Variable | Practice Type | Practice Location | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Independent N= 200 | Chain N = 202 | p-value | Rural N = 173 | Urban N = 217 | p-value | |||||
KASPER Utilization | ||||||||||
Requested Reports | 187 | 94% | 152 | 75% | <0.001* | 145 | 84% | 183 | 84% | 0.890 |
Practice Location | ||||||||||
Rural | 115 | 58% | 58 | 29% | <0.001* | - | - | - | - | - |
Urban | 75 | 38% | 142 | 70% | <0.001* | - | - | - | - | - |
Practice Type | ||||||||||
Independent | - | - | - | - | - | 115 | 66% | 75 | 34% | <0.001* |
Chain | - | - | - | - | - | 58 | 33% | 142 | 65% | <0.001* |
Years in Practice | ||||||||||
Median Years (IQR)a | 27 | 16(35) | 15 | 5(29) | <0.001* | 24 | 10(34) | 19 | 8(31) | 0.028* |
CS Dispensing Behavior | ||||||||||
Median CS dispensed per day (IQR)a | 40 | 22(60) | 50 | 30(100) | <0.001* | 50 | 25(75) | 45 | 26(75) | 0.391 |
Perceived Effectiveness of KASPER | ||||||||||
Reducing Drug Abuse and Diversion | 176 | 88% | 184 | 91% | 0.219 | 148 | 86% | 201 | 93% | 0.042* |
Reducing Doctor Shopping | 172 | 86% | 174 | 86% | 0.675 | 149 | 86% | 186 | 86% | 0.734 |
Denotes statistical significance at the 5% level.
IQR: Interquartile range